CD40L modulates CD4+ T-cell activation through receptor for activated C kinase 1

Eur J Immunol. 2023 Dec;53(12):e2350520. doi: 10.1002/eji.202350520. Epub 2023 Nov 20.

Abstract

Inhibition of the co-stimulatory ligand CD40L has shown beneficial effects in many experimental models of autoimmune disease and inflammation. Here, we show that CD40L deficiency in T cells in mice causes a reduction of CD4+ T-cell activation and specifically a strong reduction in IFN-γ-producing Th1 cells. In vitro, we could not reproduce this antigen presenting cell-dependent effects, but found that T-cell CD40L affects cell death and proliferation. We identified receptor of activated C kinase, the canonical PKC binding partner and known to drive proliferation and apoptosis, as a mediator of CD40L reverse signaling. Furthermore, we found that CD40L clustering stabilizes IFN-γ mediated Th1 polarization through STAT1, a known binding partner of receptor of activated C kinase. Together this highlights the importance of both CD40L forward and reverse signaling.

Keywords: CD4+ T cell; CD40L signaling; IFN-γ; RACK1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen-Presenting Cells
  • CD4-Positive T-Lymphocytes
  • CD40 Antigens
  • CD40 Ligand*
  • Lymphocyte Activation*
  • Mice
  • Receptors for Activated C Kinase
  • Th1 Cells

Substances

  • CD40 Ligand
  • Receptors for Activated C Kinase
  • CD40 Antigens